Citadel Advisors
NARI

Citadel Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Citadel Advisors’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-34,600
Closed -$1.77M – 15963
2024
Q4 		$1.77M Buy
34,600
+3,700
+12% +$182K ﹤0.01% 5884
2024
Q3 		$1.27M Sell
30,900
-21,700
-41% -$1.04M ﹤0.01% 6367
2024
Q2 		$2.53M Buy
52,600
+34,400
+189% +$1.52M ﹤0.01% 4880
2024
Q1 		$873K Sell
18,200
-18,100
-50% -$967K ﹤0.01% 7205
2023
Q4 		$2.36M Sell
36,300
-7,800
-18% -$470K ﹤0.01% 5082
2023
Q3 		$2.88M Buy
44,100
+12,200
+38% +$768K ﹤0.01% 4548
2023
Q2 		$1.85M Buy
31,900
+10,100
+46% +$637K ﹤0.01% 5277
2023
Q1 		$1.35M Buy
21,800
+13,000
+148% +$780K ﹤0.01% 6143
2022
Q4 		$559K Sell
8,800
-37,700
-81% -$2.73M ﹤0.01% 8012
2022
Q3 		$3.38M Buy
46,500
+1,100
+2% +$81.9K ﹤0.01% 4567
2022
Q2 		$3.09M Buy
45,400
+8,700
+24% +$625K ﹤0.01% 4712
2022
Q1 		$3.33M Buy
36,700
+2,300
+7% +$188K ﹤0.01% 4973
2021
Q4 		$3.14M Sell
34,400
-7,300
-18% -$626K ﹤0.01% 5250
2021
Q3 		$3.38M Sell
41,700
-21,200
-34% -$1.78M ﹤0.01% 5105
2021
Q2 		$5.87M Buy
62,900
+27,800
+79% +$2.69M ﹤0.01% 4101
2021
Q1 		$3.76M Buy
35,100
+16,300
+87% +$1.69M ﹤0.01% 4914
2020
Q4 		$1.64M Buy
18,800
+11,500
+158% +$812K ﹤0.01% 5794
2020
Q3 		$504K Buy
+7,300
New +$469K ﹤0.01% 7293

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $307M AUM 20.33% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return

Citadel Advisors's NARI Position: Q1 2025 in Review

Citadel Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 231,696 shares — an estimated $11.8M sold.

Citadel Advisors first reported a position in NARI in Q3 2020 and held it in 14 quarters. The position peaked at $92.3M in Q2 2021. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Citadel Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Citadel Advisors sold 231,696 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $11.8M.
  • Citadel Advisors first reported a position in Inari Medical, Inc. Common Stock in Q3 2020 and held it in 14 quarters.
  • Citadel Advisors's Inari Medical, Inc. Common Stock position peaked at $92.3M in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.